UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
about
Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients.Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis.Cold shock proteins: from cellular mechanisms to pathophysiology and disease
P2860
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
UNR/CDSE1 expression as progno ...... patients: A proof-of-concept.
@en
type
label
UNR/CDSE1 expression as progno ...... patients: A proof-of-concept.
@en
prefLabel
UNR/CDSE1 expression as progno ...... patients: A proof-of-concept.
@en
P2093
P2860
P50
P1433
P1476
UNR/CDSE1 expression as progno ...... patients: A proof-of-concept.
@en
P2093
Alberto Puime-Otin
Angel Celdrán
Arancha Cebrián
Aurea Borrero-Palacios
Fátima Gebauer
Jesus Garcia-Foncillas
Laura Del Puerto-Nevado
María Rodríguez-Remírez
Nuria Pérez
Teresa Gómez Del Pulgar
P2860
P304
P356
10.1371/JOURNAL.PONE.0182044
P407
P50
P577
2017-08-01T00:00:00Z